Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03273543 · ClinicalTrials.gov registry record · NA
Perioral Rejuvenation and Upper Lip Enhancement
A NA study, sponsored by DeNova Research.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03273543 is a NA study that has completed, run by DeNova Research. The registered enrollment target is 20 participants.
The verdict
NCT03273543, a NA study, has completed, sponsored by DeNova Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
To determine if subjects who receive premaxillary injection demonstrate an increase in nasal tip projection and an associated increase in upper lip projection, and vermillion height.
Interventions
- DEVICE Restylane® Defyne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-11-20 |
| Est. Completion | 2018-07-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03273543
The ClinicalTrials.gov registry entry for NCT03273543 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DeNova Research, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Restylane® Defyne is the first listed.
NCT03273543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03273543 about?
NCT03273543 is a clinical study titled "Perioral Rejuvenation and Upper Lip Enhancement". To determine if subjects who receive premaxillary injection demonstrate an increase in nasal tip projection and an associated increase in upper lip projection, and vermillion height.
What is the current status of trial NCT03273543?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-11-20. Estimated completion is 2018-07-03.
What interventions are being tested in trial NCT03273543?
The interventions under investigation include: Restylane® Defyne (DEVICE).
Who is sponsoring clinical trial NCT03273543?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.